Definitive Healthcare Corp.

Definitive Healthcare Corp.

DH
Definitive Healthcare Corp.US flagNASDAQ Global Select
0.88
USD
-0.08
- -
92.63MMarket Cap
Definitive Healthcare Corp.
DH
(NASDAQ Global Select)

Recent

price

0.88

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
1.35
1.81
2.2
2.23
2.16
2.26
2.28
Revenue per Share
- -
-0.6
-0.56
-0.07
-1.79
-3.54
-1.3
-1.63
Basic EPS, GAAP
- -
0.25
0.2
0.27
0.34
0.39
0.35
0.26
Free Cash Flow per Basic Share
- -
0.03
0.09
0.13
0.11
- -
- -
- -
Dividend per Share
- -
- -
-0.19
-0.25
-2.02
-5.49
-7.31
-8.77
Book Value per Share
- -
-5.44
-1.26
-1.91
-1.76
-0.72
-0.62
-0.43
Tangible Book Value per Share
- -
88
92
101
113
117
107
105
Basic Weighted Avg Shares
- -
118
166
223
251
252
242
238
Sales/Revenue/Turnover
- -
-10.24
-12.66
-16.24
-12.29
-3.86
-8.52
-7.73
Operating Margin (%)
- -
60
60
57
52
52
56
56
Depreciation Expense
- -
-53
-52
-7
-202
-413
-139
-170
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
-44.46
-31.24
-3.24
-80.5
-163.81
-57.52
-71.49
Profit Margin (%)
-34
-25
321
273
223
209
101
105
Working Capital
435
457
264
266
252
237
161
158
LT Debt
1,216
1,196
1,500
1,482
1,199
607
379
191
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-8.65
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
11
11
11
LT Borrowings
158
156
154
LT Finance Leases
6
5
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
103
104
105
Market Capitalization
437
300
129

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
246
258
246
Cash, Cash Equivalents & STI
186
181
178
Accounts Receivable, Net
35
53
40
Inventories
- -
- -
- -
Total Current Liabilities
154
157
140
Payables & Accruals
45
42
25
ST Debt
11
11
11
Deferred Revenue
92
97
99

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-16.35%
-37.58%
Free Cash Flow
- -
14.64%
-19.18%
Net Income, GAAP
- -
530.55%
-66.37%
Sales/Revenue/Turnover
- -
16.68%
-4.24%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
63
64
63
62
252
2025
59
61
60
62
242
2026
56
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.08
-1.81
-1.12
-0.51
-3.54
2025
-1.02
-0.07
-0.14
-0.09
-1.3
2026
-1.32
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Definitive Healthcare Corp. Definitive Healthcare Corp. (DH) provides software-as-a-service (SaaS) healthcare commercial intelligence through a platform that transforms data, analytics, and expertise into actionable insights for biopharma, medtech, healthcare providers, software and IT firms, and professional services; the platform features 16 intelligence modules covering sales intelligence, marketing optimization, clinical research and product development, strategy, talent acquisition, market planning, go-to-market strategies, healthcare provider affiliations, medical claims data, IDN hierarchies, RFP processes, physician prescribing habits, population health data, custom reporting, mapping, and CRM integrations. Founded in 2011 and headquartered in Framingham, Massachusetts, the company operates primarily in the United States with additional locations in Sweden and India, deriving substantially all revenue from subscription fees and support services. Recent developments include a strategic data partnership with a $10 million CapEx investment in 2024, refinancing of debt to a $175 million term loan and $50 million revolving facility extending to 2030, integration of med device sales into the biopharma team, alignment of customer success teams with sales incentives, and investments in AI-powered tools for physician analysis and enterprise customer growth driving raised 2025 revenue and profit guidance.

Company News

APIChat
  • Definitive Healthcare advances data platform and integrations to deliver smarter healthcare insights

  • Definitive Healthcare advances data platform and integrations to deliver smarter healthcare insights

  • Definitive Healthcare Corp. (DH) Q1 2026 Earnings Call Transcript

  • Definitive Healthcare Corp. (DH) Tops Q1 Earnings Estimates

  • Definitive Healthcare Reports Financial Results for First Quarter 2026

  • Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for

  • Definitive Healthcare Announces Timing of Its First Quarter 2026 Financial Results Conference Call and Webcast

  • Definitive Healthcare Corp. (DH) Q4 2025 Earnings Call Transcript

  • Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of “Hold” by Brokerages

  • Definitive Healthcare Corp. (DH) Matches Q4 Earnings Estimates

  • Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025

  • Definitive Healthcare (DH) Projected to Post Quarterly Earnings on Thursday

  • Definitive Healthcare Corp. (NASDAQ:DH) Receives Average Rating of “Hold” from Brokerages

  • Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast

  • Definitive Healthcare to Present at the 28th Annual Needham Growth Conference

  • Definitive Healthcare Corp. (DH) Q3 2025 Earnings Call Transcript

  • Definitive Healthcare Corp. (DH) Beats Q3 Earnings and Revenue Estimates

  • Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2025

  • Definitive Healthcare Announces Timing of Its Third Quarter 2025 Financial Results Conference Call and Webcast

  • Forum Ventures Bets Big on Category-Defining Vertical AI Solution for Healthcare Growth, Salubrum